IntelGenX

About:

IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.

Website: http://intelgenx.com

Twitter/X: IntelGenx

Top Investors: ATAI Life Sciences

Description:

IntelGenx is an oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP, and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full-service capabilities to its clients.

Total Funding Amount:

$38.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saint Laurent, Quebec, Canada

Founded Date:

2003-01-01

Contact Email:

Info(AT)Intelgenx.Com

Founders:

Horst G. Zerbe

Number of Employees:

11-50

Last Funding Date:

2023-08-31

IPO Status:

Public

Industries:

© 2025 bioDAO.ai